Good Studies Evaluate the Disease While Great Studies Evaluate the Patient: Development and Application of a Desirability of Outcome Ranking Endpoint for Staphylococcus aureus Bloodstream Infection-Reference-Cited by-同舟云学术

Good Studies Evaluate the Disease While Great Studies Evaluate the Patient: Development and Application of a Desirability of Outcome Ranking Endpoint for Staphylococcus aureus Bloodstream Infection

Published:2018-10-12 Issue:10 Volume:68 Page:1691-1698
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:

Author:

Doernberg Sarah B¹,Tran Thuy Tien Tram²,Tong Steven Y C³⁴,Paul Mical⁵⁶,Yahav Dafna⁷⁸,Davis Joshua S⁴⁹,Leibovici Leonard⁸¹⁰,Boucher Helen W¹¹,Corey G Ralph¹²,Cosgrove Sara E¹³,Chambers Henry F¹,Fowler Vance G¹²,Evans Scott R²,Holland Thomas L¹²,

Affiliation:

1. Department of Internal Medicine, Division of Infectious Diseases, University of California, San Francisco

2. Biostatistics Center, Department of Epidemiology and Biostatistics, Milken Institute School of Public Health, George Washington University, D.C

3. Victorian Infectious Disease Service, the Royal Melbourne Hospital, and the University of Melbourne at the Peter Doherty Institute for Infection and Immunity, Victoria, Australia

4. Global and Tropical Health Division, Menzies School of Health Research, Charles Darwin University, Northern Territory, Australia

5. Institute of Infectious Diseases, Rambam Health Care Campus

6. Faculty of Medicine, Technion, Israel Institute of Technology, Haifa

7. Unit of Infectious Diseases, Rabin Medical Center, Beilinson Hospital, Petah Tikva

8. Sackler Faculty of Medicine, Tel Aviv University, Ramat-Aviv, Israel

9. Department of Infectious Diseases, John Hunter Hospital, Newcastle, New South Wales, Australia

10. Department of Medicine E, Rabin Medical Center, Beilinson Hospital, Petah Tikva, Israel

11. Tufts Medical Center, Infectious Diseases, Boston, Massachusetts

12. Duke University Medical Center, Durham, North Carolina

13. Department of Antimicrobial Stewardship, Johns Hopkins University, Baltimore, Maryland

Funder

National Institute of Allergy and Infectious Diseases

National Institutes of Health

National Health and Medical Research Council

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

http://academic.oup.com/cid/article-pdf/68/10/1691/28543459/ciy766.pdf

Reference17 articles.

1. Comment: fundamentals and innovation in antibiotic trials;Evans;Stat Biopharm Res,2015

2. Desirability of outcome ranking (DOOR) and response adjusted for duration of antibiotic risk (RADAR);Evans;Clin Infect Dis,2015

3. Challenges in the design and interpretation of noninferiority trials;Mauri;N Engl J Med,2017

4. Using outcomes to analyze patients rather than patients to analyze outcomes: a step toward pragmatism in benefit:risk evaluation;Evans;Stat Biopharm Res,2016

5. Clinical management of Staphylococcus aureus bacteremia: a review;Holland;JAMA,2014

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application of desirability of outcome ranking to the milking in non-vigorous infants trial;Early Human Development;2024-02

2. Contemporary Management of Staphylococcus aureus Bacteremia—Controversies in Clinical Practice;Clinical Infectious Diseases;2023-11-10

3. The Next Generation: Mentoring and Diversity in the Antibacterial Resistance Leadership Group;Clinical Infectious Diseases;2023-10-15

4. Priorities and Progress in Gram-positive Bacterial Infection Research by the Antibacterial Resistance Leadership Group: A Narrative Review;Clinical Infectious Diseases;2023-10-15

5. Moving Beyond Mortality: Development and Application of a Desirability of Outcome Ranking (DOOR) Endpoint for Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia;Clinical Infectious Diseases;2023-09-22